Viking Therapeutics

+$0.06 (+1.07%) Today
-$0.03 (-0.53%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VKTX and other ETFs, options, and stocks.

About VKTX

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. The firm's clinical program VK5211, treats patients recovering from non-elective hip fracture surgery.

CEO
Brian Lian
Employees
20
Headquarters
San Diego, California
Founded
2012

VKTX Key Statistics

Market Cap
444.39M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
665.13K
High Today
$5.84
Low Today
$5.47
Open Price
$5.61
Volume
798.16K
52 Week High
$10.09
52 Week Low
$4.95

VKTX Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
-$0.20 per share
Actual
Available Jul 28, After Hours
Preview Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure